NCT00633243View on ClinicalTrials.gov

Effective Treatment of Hepatitis C in Substance Users

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Hepatitis COpiate Dependence
Interventions
PROCEDURE

Modified Directly Observed Therapy (mDOT)

PROCEDURE

Self-Administered Therapy (SAT)

Trial Locations (1)

06519

South Central Rehabilitation Agency, New Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT00633243 - Effective Treatment of Hepatitis C in Substance Users | Biotech Hunter | Biotech Hunter